Shareholders’ Equity (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
|---|
| Shareholders’ Equity [Abstract] |
|
| Schedule of Awards Granted |
During the years ended December 31, 2023, and December 2022, the following awards were granted:
| Award Type (2015 Plan) |
|
Number of
Awards in
2023 |
|
|
Number of
Awards in
2022 (*) |
|
|
Vesting
Conditions |
|
Expiration Date |
| Options |
|
|
400 |
|
|
|
16,778 |
|
|
Over 4 years from grant date-25% every year (from the second year- 2.08% each month) |
|
10th anniversary of Grant Date |
| RSU |
|
|
45,100 |
|
|
|
59,200 |
|
|
Over 3 years from grant date |
|
|
| * |
Adjusted to reflect reverse stock split, see note 2(ff). |
|
| Schedule of Share Option Activity Under Option Plans |
A summary of the Company’s share option activity under option plans is as follows:
| |
|
Number of
Options |
|
|
Weighted-
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Life |
|
| Outstanding – January 1, 2023 |
|
|
96,459 |
|
|
$ |
4.89 |
|
|
|
5.34 |
|
| Granted |
|
|
400 |
|
|
$ |
1.48 |
|
|
|
9.71 |
|
| Exercised |
|
|
(2,489 |
) |
|
$ |
0.90 |
|
|
|
|
|
| Forfeited |
|
|
(6,606 |
) |
|
$ |
22.74 |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding – December 31, 2023 |
|
|
87,764 |
|
|
$ |
3.63 |
|
|
|
4.11 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable – December 31, 2023 |
|
|
80,064 |
|
|
$ |
2.36 |
|
|
|
3.67 |
|
| |
|
Number of
Options (*) |
|
|
Weighted-
Average
Exercise
Price (*) |
|
|
Weighted
Average
Remaining
Contractual
Life |
|
| Outstanding – January 1, 2022 |
|
|
89,049 |
|
|
$ |
1.52 |
|
|
|
5.43 |
|
| Granted |
|
|
16,778 |
|
|
$ |
21.96 |
|
|
|
|
|
| Exercised |
|
|
(7,775 |
) |
|
$ |
0.81 |
|
|
|
|
|
| Forfeited |
|
|
(1,593 |
) |
|
$ |
15.09 |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding – December 31, 2022 |
|
|
96,459 |
|
|
$ |
4.89 |
|
|
|
5.34 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable – December 31, 2022 |
|
|
77,196 |
|
|
$ |
1.48 |
|
|
|
4.36 |
|
| * |
Adjusted to reflect reverse stock split, see note 2(ff). |
|
| Schedule of Ordinary Shares Issuable upon Outstanding Options and Exercisable Options |
The following table summarize information as of December 31, 2023, regarding the number of ordinary shares issuable upon outstanding options and exercisable options:
| Exercise price |
|
Options
outstanding as of
December 31,
2023 |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Options
exercisable as of
December 31,
2023 |
|
|
Weighted
average
remaining
contractual
life (years) |
|
| 0.64 |
|
|
30,309 |
|
|
|
1.61 |
|
|
|
30,309 |
|
|
|
1.61 |
|
| 1.06 |
|
|
43,461 |
|
|
|
4.44 |
|
|
|
43,402 |
|
|
|
4.43 |
|
| 1.48 |
|
|
400 |
|
|
|
9.71 |
|
|
|
100 |
|
|
|
9.71 |
|
| 5.78 |
|
|
5,500 |
|
|
|
8.96 |
|
|
|
1,750 |
|
|
|
8.96 |
|
| 13.62 |
|
|
3,894 |
|
|
|
7.41 |
|
|
|
2,524 |
|
|
|
7.41 |
|
| 40.00 |
|
|
4,200 |
|
|
|
8.72 |
|
|
|
1,979 |
|
|
|
8.72 |
|
| |
|
|
87,764 |
|
|
|
|
|
|
|
80,064 |
|
|
|
|
|
| Exercise price |
|
Options
outstanding as of
December 31,
2022 (*) |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Options
exercisable as of
December 31,
2022 |
|
|
Weighted
average
remaining
contractual
life (years) |
|
| 0.64 |
|
|
31,236 |
|
|
|
2.61 |
|
|
|
31,236 |
|
|
|
2.61 |
|
| 1.06 |
|
|
44,989 |
|
|
|
5.43 |
|
|
|
43,752 |
|
|
|
5.39 |
|
| 5.78 |
|
|
8,843 |
|
|
|
9.96 |
|
|
|
- |
|
|
|
- |
|
| 13.62 |
|
|
3,891 |
|
|
|
8.41 |
|
|
|
1,547 |
|
|
|
8.41 |
|
| 40.00 |
|
|
7,500 |
|
|
|
9.72 |
|
|
|
661 |
|
|
|
9.72 |
|
| |
|
|
96,459 |
|
|
|
|
|
|
|
77,196 |
|
|
|
|
|
| * |
Adjusted to reflect reverse stock split, see note 2(ff). |
|
| Schedule of Fair Value of the Share Options Granted |
Key assumptions used to estimate the
fair value of the share options granted during the year ended December 31, 2022 included:
| |
|
|
|
| |
|
2022 |
|
| Expected term of options (years) |
|
|
10 |
|
| Expected common stock price volatility** |
|
|
54 |
% |
| Expected dividend rate |
|
|
0 |
% |
| Risk-free interest rate |
|
|
3.21%-3.25 |
% |
| ** | The expected volatility was based on the historical stock prices of publicly traded comparable companies. |
|
| Schedule of Share-Based Compensation Expense for Share Options |
Share-based compensation expense for share options in the consolidated statements of comprehensive loss is summarized as follows:
| |
|
Year Ended
December 31, |
|
| |
|
2023 |
|
|
2022 |
|
| Cost of revenues |
|
|
3 |
|
|
|
3 |
|
| Research and development |
|
|
23 |
|
|
|
26 |
|
| Sales and marketing |
|
|
11 |
|
|
|
11 |
|
| General and administrative |
|
|
11 |
|
|
|
12 |
|
| Total Share-based compensation expense |
|
|
48 |
|
|
|
52 |
|
Share-based compensation expense for
RSUs in the consolidated statement of comprehensive loss is summarized as follows:
| |
|
Year Ended
December 31 |
|
| |
|
2023 |
|
|
2022 |
|
| |
|
U.S. dollars in thousands |
|
| Cost of revenues |
|
|
9 |
|
|
|
3 |
|
| Research and development |
|
|
53 |
|
|
|
18 |
|
| Sales and marketing |
|
|
47 |
|
|
|
12 |
|
| General and administrative |
|
|
220 |
|
|
|
135 |
|
| Total Share-based compensation expense |
|
|
329 |
|
|
|
168 |
|
|
| Schedule of RSUs Activity under Option Plans |
A summary of the Company’s RSUs activity under option
plans is as follows:
| |
|
Year ended
December 31, 2023 |
|
|
Year ended
December 31, 2022 |
|
| |
|
Number of
RSUs |
|
|
Weighted-
Average Grant
Date Fair Value |
|
|
Number of
RSUs (*) |
|
|
Weighted-
Average Grant
Date Fair Value |
|
| RSUs outstanding at the beginning of the year |
|
|
59,200 |
|
|
$ |
16.20 |
|
|
|
- |
|
|
|
- |
|
| Granted during the year |
|
|
43,100 |
|
|
$ |
3.33 |
|
|
|
59,200 |
|
|
$ |
16.20 |
|
| Vested during the year |
|
|
(29,520 |
) |
|
|
12.36 |
|
|
|
- |
|
|
|
- |
|
| Forfeited during the year |
|
|
(1,500 |
) |
|
|
16.20 |
|
|
|
- |
|
|
|
- |
|
| Outstanding at the end of the year |
|
|
71,280 |
|
|
$ |
10.35 |
|
|
|
59,200 |
|
|
$ |
16.20 |
|
| * |
Adjusted to reflect reverse stock split, see note 2(ff). |
|